1 / 20

Taiwan Unrelated Donor PBSC Harvest Experience

Taiwan Unrelated Donor PBSC Harvest Experience. Shu-Huey Chen Hualien Tzu-Chi General Hospital. Impact of donor characteristics and procedural settings in yield Donor characteristics in G-CSF side effect and post G-CSF WBC in predicting side effect Second donation MCV.

Download Presentation

Taiwan Unrelated Donor PBSC Harvest Experience

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Taiwan Unrelated Donor PBSC Harvest Experience Shu-Huey Chen Hualien Tzu-Chi General Hospital

  2. Impact of donor characteristics and procedural settings in yield • Donor characteristics in G-CSF side effect and post G-CSF WBC in predicting side effect • Second donation • MCV

  3. Materials and Methods ( І) • Jan. 2003〜Mar. 2008, 373 unrelated healthy donors. G-CSF sc, 8.3-11μg/kg, daily for 5 days, harvest on day 5 of G-CSF(Filgrastim)

  4. Materials and Methods(Ⅱ) • CD34+ cell criteria : >5  106 CD34+ cells/ kg recipient BW, If the first apheresis(D1) failed, following day a second apheresis(D2) • D1 apheresis volume: patient body weight <35 kg→12 liters; 35-45 kg →15 liters; >45 kg →18 liters D2 apheresis volume: 6-12 liters( D1 + D2 ≤24 liters)

  5. Materials and Methods(Ⅲ) • BMI (kg/m2) : body weight (kg) divided by the square of their height (m). • CIC(circulating immature cell )= circulating myeloblasts, promyelocytes, and myelocytes, metamyelocytes and erythroblasts • The number of CD34+ cells : resultant leukapheresis bag using a PE-conjugated anti-CD34+ cell antibody (HPCA2) and flow cytometry (Becton Dickinson, San Jose, Ca, USA).

  6. Yield • Convention outcome: CD34+ cells /donor BW (106/kg ) CD34+ cells / recipient BW (106/kg) • This study outcome: CD34+ cell yield (106/L of processed blood) Poor yield: <10 x 106 CD34+ cells per L of processed blood volume a maximum of two aphereses of 24 liters of processed blood volume yielding 4 x 106 CD34+ cells/ kg for a recipient with BW of 60 kg

  7. Results Ⅰ

  8. Results Ⅱ

  9. Results Ⅲ Female: low BMI, high artery, low total CD34, CD34/recipient kg, and yield

  10. Results Ⅳ • female donors artery access did exhibit higher CD34+ cell yields

  11. Results Ⅴ donor age↑, female, low BMI, low pre-harvest WBC and circulating immature cell count, venous access type and high flow rate correlated with low Day 1 yield

  12. Results Ⅵ female gender, an older age, a higher flow rate and venous access a higher risk for poor yield

  13. DISCUSSION • Outcome of harvest: mobilization and harvest • Harvest(procedural setting): less been studies • Suzuya : flow rate negatively correlated with the outcome of stem cell harvest ; CD34+ cells were higher in the arterial group but the differences didn’t reach the significance • Our study: the mean harvest stem cell counts were also not significantly different if data viewed as a whole, but in female donors venous access did exhibit lower CD34+ cell yields • Difficult to explain: arterial access will have a lesser stem cells trapping in the pulmonary circulation;more obvious in low circulating stem cells.

  14. Donor characteristics in G-CSF side effect and post G-CSF WBC in predicting side effect Jan./2008 to Dec./2009

  15. Table 2 Incidences of adverse events

  16. Female(all S/S), high BMI(fatigue, myalgia/arthralgia, sweat), High G-CSF dose(bone pain), High 3rd day WBC(fatigue)

  17. Second Donation(May./1994 to May./2009) 63.6%(7/11) donor choose BM; Fixed experienced staff for vascular access, Routine concomitant calcium gluconate supplement, Reduce processing blood volume for low body weight donor

  18. Poor mobilizer

  19. 感恩您的聆聽! 人本醫療 尊重生命 福田一方邀天下善士 心蓮萬蕊造慈濟世界

More Related